Evidence map›Paper›PMID 29849140›Full record

ArticleNature2018

Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors.

Lai N Chan, Zhengshan Chen, Daniel Braas, Jae-Woong Lee, Gang Xiao, Huimin Geng, Kadriye Nehir Cosgun, Christian Hurtz, Seyedmehdi Shojaee, Valeria Cazzaniga and 17 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 14 institutions in 7 countries.

Lai N ChanDepartment of Systems Biology, Beckman Research Institute and City of Hope National Medical Center, Pasadena, California, 91016, USA.
Zhengshan ChenDepartment of Systems Biology, Beckman Research Institute and City of Hope National Medical Center, Pasadena, California, 91016, USA.
Daniel BraasDepartment of Molecular and Medical Pharmacology, UCLA Metabolomics Center and Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, California, 90095, USA.
Jae-Woong LeeDepartment of Systems Biology, Beckman Research Institute and City of Hope National Medical Center, Pasadena, California, 91016, USA.
Gang XiaoDepartment of Systems Biology, Beckman Research Institute and City of Hope National Medical Center, Pasadena, California, 91016, USA.
Huimin GengDepartments of Laboratory Medicine and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, 94143, USA.
Kadriye Nehir CosgunDepartment of Systems Biology, Beckman Research Institute and City of Hope National Medical Center, Pasadena, California, 91016, USA.
Christian HurtzDepartments of Laboratory Medicine and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, 94143, USA.
Seyedmehdi ShojaeeDepartments of Laboratory Medicine and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, 94143, USA.
Valeria CazzanigaDepartments of Laboratory Medicine and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, 94143, USA.
Hilde SchjervenDepartments of Laboratory Medicine and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, 94143, USA.
Thomas ErnstHämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, 07743, Jena, Germany.
Andreas HochhausHämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, 07743, Jena, Germany.
Steven M KornblauDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, USA.
Marina KonoplevaDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, USA.
Miles A PufallDepartment of Biochemistry, University of Iowa, Iowa City, Iowa, 52242, USA.
Giovanni CazzanigaCentro Ricerca Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Ospedale S. Gerardo, 20052, Monza, MB, Italy.
Grace J LiuAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, 3004, Australia.
Thomas A MilneMRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.
H Phillip KoefflerCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.
Theodora S RossDepartment of Internal Medicine and Cancer Genetics, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
Isidro Sánchez-GarcíaExperimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca and Institute of Biomedical Research of Salamanca (IBSAL), 37007, Salamanca, Spain.
Arndt BorkhardtPediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany.
Keith R YamamotoDepartments of Laboratory Medicine and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, 94143, USA.
Ross A DickinsAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, 3004, Australia.
Thomas G GraeberDepartment of Molecular and Medical Pharmacology, UCLA Metabolomics Center and Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, California, 90095, USA.
Markus MüschenDepartment of Systems Biology, Beckman Research Institute and City of Hope National Medical Center, Pasadena, California, 91016, USA. mmuschen@coh.org.
University of California, San Francisco · USCity of Hope · USCity Of Hope National Medical Center · USJena University Hospital · DEMonash University · AUThe University of Texas MD Anderson Cancer Center · USUniversity of California, Los Angeles · USCancer Genetics (United States) · USHeinrich Heine University Düsseldorf · DENational University of Singapore · SGUniversidad de Salamanca · ESUniversity of Iowa · USUniversity of Milano-Bicocca · ITUniversity of Oxford · GB

Funding

GENE REGULATION BY STEROID RECEPTOR PROTEINSR01CA020535 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAMAMOTO, KEITH ROBERT · 1985 to 2018
$8.9M
NCI NIH HHS R01 CA020535
6 · The paper itself

Abstract

In Fig. 3c of this Letter, the the effects of CRISPR-Cas9-mediated deletion of NR3C1, TXNIP and CNR2 in patient-derived B-lineage leukaemia cells were shown. For curves depicting NR3C1 (left graph), data s for TXNIP (middle graph) were inadvertently plotted. This figure has been corrected online, and the original Fig. 3c is shown as Supplementary Information to this Amendment for transparency. The error does not affect the conclusions of the Letter. In addition, Source Data files have been added for the Figs. 1-4 and Extended Data Figs. 1-10 of the original Letter.

Identifiers

PMID29849140
OpenAlexW2803812047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.